Contact Us
Center for Rare Disease Therapies535 Watson Drive
Claremont, CA 91711 Phone: (909) 607-0120
Email: CRDT
Center News
Benefits of the Orphan Drug Act for Rare Disease Treatments
March 25, 2010
TuftScope, a journal of health, ethics and policy at Tufts University, has published a paper by three KGI students—Boris Gites, Mona Chughtai and Jessica Chang—plus Professor M. Ian Philips, director of KGI’s Center for Rare Disease Therapies, on the positive changes brought about by the Orphan Drug Act to combat rare diseases.
March 25, 2010
TuftScope, a journal of health, ethics and policy at Tufts University, has published a paper by three KGI students—Boris Gites, Mona Chughtai and Jessica Chang—plus Professor M. Ian Philips, director of KGI’s Center for Rare Disease Therapies, on the positive changes brought about by the Orphan Drug Act to combat rare diseases.
First-time Orphan Drug Workshop at KGI Deemed ‘Historic, Innovative’
March 18, 2010
The Center for Rare Disease Therapies at KGI recently partnered with the U. S. Food and Drug Administration to host a historic two-day workshop.
March 18, 2010
The Center for Rare Disease Therapies at KGI recently partnered with the U. S. Food and Drug Administration to host a historic two-day workshop.
KGI-hosted FDA Workshop Discussed in Wall Street Journal
March 10, 2010
Staff members at the Food and Drug Administration are doing something unusual. They are leaving Washington to help drug makers take a crucial step in developing drugs for rare diseases.
March 10, 2010
Staff members at the Food and Drug Administration are doing something unusual. They are leaving Washington to help drug makers take a crucial step in developing drugs for rare diseases.
Prof. Phillips Elected Fellow of AAAS
January 18, 2010
M. Ian Phillips, KGI's Norris Professor of Applied Life Sciences, has been named a Fellow by the American Association for the Advancement of Science (AAAS), an elite group of scientists that includes Nobel Prize winners and members of the National Academy of Sciences.
January 18, 2010
M. Ian Phillips, KGI's Norris Professor of Applied Life Sciences, has been named a Fellow by the American Association for the Advancement of Science (AAAS), an elite group of scientists that includes Nobel Prize winners and members of the National Academy of Sciences.
FDA Launches Orphan Drug Workshop at KGI
December 9, 2009
The U.S. Food and Drug Administration (FDA) has announced the launch of an orphan drug workshop series-an opportunity for biotechnology companies, pharmaceutical firms, academics and other interested parties to spend two days creating applications for orphan status designation, under the guidance of staff from FDA's Office of Orphan Products Development (OOPD). The first workshop is planned for Feb. 25-26, 2010, hosted by the Center for Rare Disease Therapies at Keck Graduate Institute (KGI) in Claremont, Calif.
December 9, 2009
The U.S. Food and Drug Administration (FDA) has announced the launch of an orphan drug workshop series-an opportunity for biotechnology companies, pharmaceutical firms, academics and other interested parties to spend two days creating applications for orphan status designation, under the guidance of staff from FDA's Office of Orphan Products Development (OOPD). The first workshop is planned for Feb. 25-26, 2010, hosted by the Center for Rare Disease Therapies at Keck Graduate Institute (KGI) in Claremont, Calif.
Rare Disease Center Hosts Symposium on New Strategies
October 27, 2009
Top leaders from industry, government, science and patient advocacy groups shared the challenges and opportunities of developing drug therapies to treat rare disease at a recent mini-symposium hosted by KGI's Center for Rare Disease Therapies.
October 27, 2009
Top leaders from industry, government, science and patient advocacy groups shared the challenges and opportunities of developing drug therapies to treat rare disease at a recent mini-symposium hosted by KGI's Center for Rare Disease Therapies.
Stem Cells: Health Care's Magic Bullet
August 26, 2009
KGI Professor Ian Phillips is featured in the September issue of Inland Empire Magazine discussing his love of art and his passion for science to create new ways to save lives.
August 26, 2009
KGI Professor Ian Phillips is featured in the September issue of Inland Empire Magazine discussing his love of art and his passion for science to create new ways to save lives.
Rare Disease Center Sponsors Internships in Washington, DC
August 7, 2009
Three Keck Graduate Institute students are gaining invaluable field experience this summer through internships sponsored by KGI's Center for Rare Disease Therapies. Sonali Talele and Aditya Kelkar are interning at the Food and Drug Administration in the Office of Orphan Products Development (OOPD) in Washington, DC, while Brent Thompson is working in Scientific & Regulatory Affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA), also located in the capitol.
August 7, 2009
Three Keck Graduate Institute students are gaining invaluable field experience this summer through internships sponsored by KGI's Center for Rare Disease Therapies. Sonali Talele and Aditya Kelkar are interning at the Food and Drug Administration in the Office of Orphan Products Development (OOPD) in Washington, DC, while Brent Thompson is working in Scientific & Regulatory Affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA), also located in the capitol.
KGI Center for Rare Disease Therapies Praises New NIH Initiative
May 26, 2009
Leaders of the Center for Rare Disease Therapies (CRDT) at Keck Graduate Institute welcomed the news that the National Institutes of Health (NIH) will launch a new program dedicated to tackling rare and neglected diseases.
May 26, 2009
Leaders of the Center for Rare Disease Therapies (CRDT) at Keck Graduate Institute welcomed the news that the National Institutes of Health (NIH) will launch a new program dedicated to tackling rare and neglected diseases.
KGI Center for Rare Disease Therapies Praises New NIH Initiative
May 26, 2009
Leaders of the Center for Rare Disease Therapies (CRDT) at Keck Graduate Institute welcomed the news that the National Institutes of Health (NIH) will launch a new program dedicated to tackling rare and neglected diseases.
May 26, 2009
Leaders of the Center for Rare Disease Therapies (CRDT) at Keck Graduate Institute welcomed the news that the National Institutes of Health (NIH) will launch a new program dedicated to tackling rare and neglected diseases.